| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.78e-03 | 188 | 10 | 2 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.18e-03 | 749 | 10 | 3 | GO:0005509 | |
| GeneOntologyMolecularFunction | phosphatase activity | 8.58e-03 | 287 | 10 | 2 | GO:0016791 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.05e-05 | 445 | 10 | 4 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 5.53e-05 | 482 | 10 | 4 | GO:0007178 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 2.65e-04 | 276 | 10 | 3 | GO:0007179 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte proliferation | 3.21e-04 | 56 | 10 | 2 | GO:0010837 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 4.72e-04 | 336 | 10 | 3 | GO:0071560 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 4.93e-04 | 850 | 10 | 4 | GO:0071363 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 5.02e-04 | 343 | 10 | 3 | GO:0071559 | |
| GeneOntologyBiologicalProcess | keratinocyte proliferation | 5.02e-04 | 70 | 10 | 2 | GO:0043616 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5.19e-04 | 347 | 10 | 3 | GO:0090092 | |
| GeneOntologyBiologicalProcess | response to growth factor | 5.70e-04 | 883 | 10 | 4 | GO:0070848 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 8.55e-04 | 412 | 10 | 3 | GO:0090287 | |
| GeneOntologyBiologicalProcess | B cell activation involved in immune response | 1.04e-03 | 101 | 10 | 2 | GO:0002312 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | 1.73e-03 | 1186 | 10 | 4 | GO:0007167 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 1.93e-03 | 138 | 10 | 2 | GO:0030512 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 2.22e-03 | 148 | 10 | 2 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 2.22e-03 | 148 | 10 | 2 | GO:0035113 | |
| GeneOntologyBiologicalProcess | regulation of JNK cascade | 2.62e-03 | 161 | 10 | 2 | GO:0046328 | |
| GeneOntologyBiologicalProcess | response to UV | 2.81e-03 | 167 | 10 | 2 | GO:0009411 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.43e-03 | 185 | 10 | 2 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.43e-03 | 185 | 10 | 2 | GO:0035108 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 3.69e-03 | 192 | 10 | 2 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 3.81e-03 | 195 | 10 | 2 | GO:1903844 | |
| GeneOntologyBiologicalProcess | placenta development | 3.88e-03 | 197 | 10 | 2 | GO:0001890 | |
| GeneOntologyBiologicalProcess | JNK cascade | 3.92e-03 | 198 | 10 | 2 | GO:0007254 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 4.11e-03 | 713 | 10 | 3 | GO:0048598 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4.73e-03 | 218 | 10 | 2 | GO:0090101 | |
| GeneOntologyBiologicalProcess | limb development | 4.99e-03 | 224 | 10 | 2 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 4.99e-03 | 224 | 10 | 2 | GO:0048736 | |
| Domain | EGF_CA | 1.11e-05 | 86 | 10 | 3 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.59e-05 | 97 | 10 | 3 | IPR018097 | |
| Domain | EGF_CA | 1.69e-05 | 99 | 10 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.74e-05 | 100 | 10 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.07e-05 | 106 | 10 | 3 | IPR000152 | |
| Domain | EGF_CA | 3.16e-05 | 122 | 10 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.31e-05 | 124 | 10 | 3 | IPR001881 | |
| Domain | Growth_fac_rcpt_ | 6.57e-05 | 156 | 10 | 3 | IPR009030 | |
| Domain | hEGF | 9.68e-05 | 28 | 10 | 2 | PF12661 | |
| Domain | EGF | 2.21e-04 | 235 | 10 | 3 | SM00181 | |
| Domain | EGF_3 | 2.21e-04 | 235 | 10 | 3 | PS50026 | |
| Domain | EGF-like_dom | 2.62e-04 | 249 | 10 | 3 | IPR000742 | |
| Domain | EGF_1 | 2.81e-04 | 255 | 10 | 3 | PS00022 | |
| Domain | EGF-like_CS | 3.01e-04 | 261 | 10 | 3 | IPR013032 | |
| Domain | EGF_2 | 3.15e-04 | 265 | 10 | 3 | PS01186 | |
| Domain | I-set | 4.39e-03 | 190 | 10 | 2 | PF07679 | |
| Domain | Ig_I-set | 4.39e-03 | 190 | 10 | 2 | IPR013098 | |
| Domain | ConA-like_dom | 5.79e-03 | 219 | 10 | 2 | IPR013320 | |
| Domain | Ig_sub | 2.02e-02 | 421 | 10 | 2 | IPR003599 | |
| Domain | IG | 2.02e-02 | 421 | 10 | 2 | SM00409 | |
| Pubmed | Suppression of epithelial differentiation by Foxi3 is essential for molar crown patterning. | 3.22e-05 | 30 | 10 | 2 | 26450968 | |
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 7.81e-05 | 307 | 10 | 3 | 37499664 | |
| Pubmed | The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes. | 1.73e-04 | 69 | 10 | 2 | 26792178 | |
| Pubmed | 1.90e-04 | 1116 | 10 | 4 | 31753913 | ||
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 2.03e-04 | 424 | 10 | 3 | 21731673 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.51e-04 | 1201 | 10 | 4 | 35696571 | |
| Interaction | ZFP41 interactions | 2.54e-06 | 57 | 10 | 3 | int:ZFP41 | |
| Interaction | PXDN interactions | 8.21e-06 | 84 | 10 | 3 | int:PXDN | |
| Interaction | LTBP1 interactions | 1.08e-05 | 92 | 10 | 3 | int:LTBP1 | |
| Interaction | FBXO2 interactions | 3.25e-05 | 411 | 10 | 4 | int:FBXO2 | |
| Interaction | ZNF627 interactions | 4.19e-05 | 20 | 10 | 2 | int:ZNF627 | |
| Interaction | ZNF408 interactions | 4.22e-05 | 145 | 10 | 3 | int:ZNF408 | |
| Interaction | NTN5 interactions | 6.08e-05 | 24 | 10 | 2 | int:NTN5 | |
| Interaction | EMILIN2 interactions | 7.73e-05 | 27 | 10 | 2 | int:EMILIN2 | |
| Interaction | ZNF136 interactions | 1.38e-04 | 36 | 10 | 2 | int:ZNF136 | |
| Interaction | GREM2 interactions | 1.46e-04 | 37 | 10 | 2 | int:GREM2 | |
| Interaction | PRG3 interactions | 2.57e-04 | 49 | 10 | 2 | int:PRG3 | |
| Interaction | FOXD4L6 interactions | 2.57e-04 | 49 | 10 | 2 | int:FOXD4L6 | |
| Interaction | LYPD1 interactions | 3.61e-04 | 58 | 10 | 2 | int:LYPD1 | |
| Interaction | PLAT interactions | 4.26e-04 | 63 | 10 | 2 | int:PLAT | |
| Interaction | NPHS2 interactions | 4.39e-04 | 64 | 10 | 2 | int:NPHS2 | |
| Interaction | FBN2 interactions | 4.53e-04 | 65 | 10 | 2 | int:FBN2 | |
| Interaction | LTBP4 interactions | 4.82e-04 | 67 | 10 | 2 | int:LTBP4 | |
| Interaction | WNT5A interactions | 5.11e-04 | 69 | 10 | 2 | int:WNT5A | |
| Interaction | PTPRM interactions | 5.56e-04 | 72 | 10 | 2 | int:PTPRM | |
| Interaction | IGFL3 interactions | 6.03e-04 | 75 | 10 | 2 | int:IGFL3 | |
| Interaction | EGFL7 interactions | 6.36e-04 | 77 | 10 | 2 | int:EGFL7 | |
| Interaction | UBR3 interactions | 1.05e-03 | 99 | 10 | 2 | int:UBR3 | |
| Interaction | TRIM33 interactions | 1.20e-03 | 453 | 10 | 3 | int:TRIM33 | |
| Interaction | RABGGTB interactions | 1.25e-03 | 108 | 10 | 2 | int:RABGGTB | |
| Interaction | KLK5 interactions | 1.27e-03 | 109 | 10 | 2 | int:KLK5 | |
| Interaction | MATN2 interactions | 1.36e-03 | 113 | 10 | 2 | int:MATN2 | |
| GeneFamily | Immunoglobulin like domain containing | 2.30e-03 | 193 | 7 | 2 | 594 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP | 3.39e-05 | 175 | 10 | 3 | M6723 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.40e-05 | 191 | 10 | 3 | MM17059 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN | 4.75e-05 | 196 | 10 | 3 | M8675 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.75e-05 | 196 | 10 | 3 | M3008 | |
| Coexpression | GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN | 4.83e-05 | 197 | 10 | 3 | M3255 | |
| Coexpression | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN | 7.74e-05 | 35 | 10 | 2 | M13220 | |
| Coexpression | NABA_CORE_MATRISOME | 1.23e-04 | 270 | 10 | 3 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.30e-04 | 275 | 10 | 3 | M5884 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 3.21e-04 | 71 | 10 | 2 | M2948 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 3.49e-04 | 385 | 10 | 3 | M39264 | |
| Coexpression | NABA_MATRISOME | 3.79e-04 | 1008 | 10 | 4 | MM17056 | |
| Coexpression | NABA_MATRISOME | 4.06e-04 | 1026 | 10 | 4 | M5889 | |
| Coexpression | ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON | 4.49e-04 | 84 | 10 | 2 | M39095 | |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_UP | 7.68e-04 | 110 | 10 | 2 | M1696 | |
| Coexpression | DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS | 8.39e-04 | 115 | 10 | 2 | M40201 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS | 8.54e-04 | 116 | 10 | 2 | M40251 | |
| Coexpression | LEE_NEURAL_CREST_STEM_CELL_DN | 9.44e-04 | 122 | 10 | 2 | M10276 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | 1.01e-03 | 555 | 10 | 3 | M2343 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 1.08e-03 | 567 | 10 | 3 | M2129 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.15e-03 | 135 | 10 | 2 | M5825 | |
| Coexpression | PROVENZANI_METASTASIS_DN | 1.27e-03 | 142 | 10 | 2 | M9016 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 1.69e-03 | 164 | 10 | 2 | M13108 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 2.01e-03 | 179 | 10 | 2 | M39308 | |
| Coexpression | GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN | 2.26e-03 | 190 | 10 | 2 | M6496 | |
| Coexpression | RPS14_DN.V1_UP | 2.29e-03 | 191 | 10 | 2 | M2816 | |
| Coexpression | SHEPARD_CRASH_AND_BURN_MUTANT_DN | 2.29e-03 | 191 | 10 | 2 | M2148 | |
| Coexpression | AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1 | 2.29e-03 | 191 | 10 | 2 | M39108 | |
| Coexpression | GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP | 2.31e-03 | 192 | 10 | 2 | M4660 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP | 2.33e-03 | 193 | 10 | 2 | M9233 | |
| Coexpression | GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP | 2.36e-03 | 194 | 10 | 2 | M5136 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 2.36e-03 | 194 | 10 | 2 | M3321 | |
| Coexpression | GSE25087_TREG_VS_TCONV_ADULT_DN | 2.38e-03 | 195 | 10 | 2 | M4652 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 2.38e-03 | 195 | 10 | 2 | M9808 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP | 2.41e-03 | 196 | 10 | 2 | M4423 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN | 2.41e-03 | 196 | 10 | 2 | M8685 | |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 2.41e-03 | 196 | 10 | 2 | M3243 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_MAC_DN | 2.43e-03 | 197 | 10 | 2 | M5161 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 2.43e-03 | 197 | 10 | 2 | M6512 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_UP | 2.46e-03 | 198 | 10 | 2 | M4413 | |
| Coexpression | GSE25087_FETAL_VS_ADULT_TREG_UP | 2.46e-03 | 198 | 10 | 2 | M4641 | |
| Coexpression | GSE6259_BCELL_VS_CD4_TCELL_DN | 2.46e-03 | 198 | 10 | 2 | M6733 | |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN | 2.48e-03 | 199 | 10 | 2 | M8100 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP | 2.48e-03 | 199 | 10 | 2 | M8107 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN | 2.48e-03 | 199 | 10 | 2 | M9963 | |
| Coexpression | GSE25087_FETAL_VS_ADULT_TCONV_UP | 2.48e-03 | 199 | 10 | 2 | M4645 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | 2.48e-03 | 199 | 10 | 2 | M8031 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP | 2.48e-03 | 199 | 10 | 2 | M9345 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 2.50e-03 | 200 | 10 | 2 | M9041 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN | 2.50e-03 | 200 | 10 | 2 | M3747 | |
| Coexpression | GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN | 2.50e-03 | 200 | 10 | 2 | M7269 | |
| Coexpression | GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP | 2.50e-03 | 200 | 10 | 2 | M7279 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 2.50e-03 | 200 | 10 | 2 | M4016 | |
| Coexpression | GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN | 2.50e-03 | 200 | 10 | 2 | M8602 | |
| Coexpression | GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP | 2.50e-03 | 200 | 10 | 2 | M5119 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN | 2.50e-03 | 200 | 10 | 2 | M8648 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_UP | 2.50e-03 | 200 | 10 | 2 | M5730 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TCONV_DN | 2.50e-03 | 200 | 10 | 2 | M5750 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 2.50e-03 | 200 | 10 | 2 | M4456 | |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN | 2.50e-03 | 200 | 10 | 2 | M5806 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 2.50e-03 | 200 | 10 | 2 | M4948 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP | 2.50e-03 | 200 | 10 | 2 | M3636 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 2.50e-03 | 200 | 10 | 2 | M5930 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 2.50e-03 | 200 | 10 | 2 | M6057 | |
| Coexpression | GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP | 2.50e-03 | 200 | 10 | 2 | M2933 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_DN | 2.50e-03 | 200 | 10 | 2 | M5676 | |
| Coexpression | GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN | 2.50e-03 | 200 | 10 | 2 | M4136 | |
| Coexpression | GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN | 2.50e-03 | 200 | 10 | 2 | M6943 | |
| Coexpression | GSE13306_TREG_RA_VS_TCONV_RA_UP | 2.50e-03 | 200 | 10 | 2 | M3226 | |
| Coexpression | GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN | 2.50e-03 | 200 | 10 | 2 | M4338 | |
| CoexpressionAtlas | Mesoderm Day 30-method_NA_vs_Mesoderm Day 30-method_episomal-Confounder_removed-fold2.0_adjp0.05 | 1.76e-06 | 207 | 10 | 4 | PCBC_ratio_MESO-30_from-ESC_vs_MESO-30_from-episomal_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_NA_vs_Mesoderm Day 30-reprogram_OSK-L-l-p53KD-Confounder_removed-fold2.0_adjp0.05 | 1.76e-06 | 207 | 10 | 4 | PCBC_ratio_MESO-30_from-ESC_vs_MESO-30_from-OSK-L-l-p53KD_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 2.83e-05 | 418 | 10 | 4 | PCBC_ratio_MESO-5 amniotic fluid MSC_vs_MESO-5 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.76e-04 | 288 | 10 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 4.09e-04 | 65 | 10 | 2 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#4_top-relative-expression-ranked_200 | 4.47e-04 | 68 | 10 | 2 | gudmap_developingKidney_e13.5_podocyte cells_200_k4 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_200 | 6.50e-04 | 82 | 10 | 2 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_500 | 6.50e-04 | 82 | 10 | 2 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 6.60e-04 | 388 | 10 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 8.37e-04 | 421 | 10 | 3 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.46e-06 | 172 | 10 | 3 | 41ddfb316429efef5f3fa0b0621ced383d9206f0 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.92e-06 | 176 | 10 | 3 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 178 | 10 | 3 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.84e-06 | 191 | 10 | 3 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.98e-06 | 192 | 10 | 3 | ef8970e5389bd55c1624cd6dd01a7ca7abaa8950 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 9.12e-06 | 193 | 10 | 3 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.12e-06 | 193 | 10 | 3 | 95f5611dd9583f339b7c9f52bb478af204fb89ad | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|COVID-19_Severe / Disease condition and Cell class | 9.12e-06 | 193 | 10 | 3 | 8ece109352d67b6a76bc87a2579e299c77c63137 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-06 | 194 | 10 | 3 | 2507f6dc7f1fe8b91fe1e24497d26d05afc3cd21 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-06 | 194 | 10 | 3 | 95dfbd9d9b8a47801edcfc35fb0d685901dcd2f8 | |
| ToppCell | COVID-19_Mild-CD8+_T_naive|COVID-19_Mild / Disease condition and Cell class | 9.26e-06 | 194 | 10 | 3 | 4e42df4f6db456ab914ddfb2a938dfc462f8b6bf | |
| ToppCell | (221)_CD8+_Naive_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 9.70e-06 | 197 | 10 | 3 | 59621a1f016b9f467e69bd5977ccdafa03b4ce21 | |
| ToppCell | (2)_NK/T-(221)_CD8+_Naive_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 9.70e-06 | 197 | 10 | 3 | 5943f30288d4c9a7d7ef2e85461487a229f44511 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-04 | 133 | 10 | 2 | f7d0763b5eec2db33044d6850fd57462494038c1 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.75e-04 | 148 | 10 | 2 | 223d6a640f3c34e73646a615593b9c0b4a4cbd6f | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 4.82e-04 | 149 | 10 | 2 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_Naive|ICU-SEP / Disease, Lineage and Cell Type | 4.82e-04 | 149 | 10 | 2 | a66f3ebf6214b269b137ddd5f4d8d7fb3ef2d962 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 4.82e-04 | 149 | 10 | 2 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.95e-04 | 151 | 10 | 2 | e1ffd99001b6a5b795f3367882a9355955c0e569 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 152 | 10 | 2 | a70fa4b40350852af3519d4eb1653bd290ed7214 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD8_Naive|Int-URO / Disease, Lineage and Cell Type | 5.01e-04 | 152 | 10 | 2 | 52d6f9cf1f4637c922f582705d625b4cbe3dc0c2 | |
| ToppCell | ileum-BEST4+_Enterocytes|ileum / shred on tissue and cell subclass | 5.14e-04 | 154 | 10 | 2 | 608e9c982125e0c2c15b86b1920813845a0db81f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-04 | 155 | 10 | 2 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-04 | 155 | 10 | 2 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | severe_COVID-19-CD8+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.28e-04 | 156 | 10 | 2 | 47aa46cdf5af9834f4b890ac6ce5e8d548ee98db | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 5.35e-04 | 157 | 10 | 2 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 5.41e-04 | 158 | 10 | 2 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | Healthy/Control-CD8+_T_naive|World / Disease group and Cell class | 5.41e-04 | 158 | 10 | 2 | 70680b29428b6bf882b1fae36f924b775961176b | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 5.41e-04 | 158 | 10 | 2 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 5.41e-04 | 158 | 10 | 2 | ab05f6d7968ccd6d3826cd71b763dbedc83822c3 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.48e-04 | 159 | 10 | 2 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | Healthy/Control-CD8+_T_naive|Healthy/Control / Disease group and Cell class | 5.55e-04 | 160 | 10 | 2 | e1386c21fcbbf57fa32d8bdfba3cb1887477ff73 | |
| ToppCell | Healthy_donor-CD8+_T_naive|World / disease group, cell group and cell class (v2) | 5.62e-04 | 161 | 10 | 2 | 8a61395af33132783a0a37956c6f821aba5d3b1e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-04 | 161 | 10 | 2 | 1f4614ae15bd2fc08e555cea4d0152c4a940d048 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_P4HA3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-04 | 162 | 10 | 2 | dd4a08af653095ad4f63112312715589a1d43b38 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1-2_PAX6_SCGN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.90e-04 | 165 | 10 | 2 | 8597d99cf896e8e47856fe9a6e8f19f62ed05ad2 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.04e-04 | 167 | 10 | 2 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.12e-04 | 168 | 10 | 2 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.12e-04 | 168 | 10 | 2 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.12e-04 | 168 | 10 | 2 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | Healthy_donor-CD8+_T_naive|Healthy_donor / disease group, cell group and cell class (v2) | 6.19e-04 | 169 | 10 | 2 | 66216758e581365f10c2a66714d83a606ad23af0 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.19e-04 | 169 | 10 | 2 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.26e-04 | 170 | 10 | 2 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-04 | 171 | 10 | 2 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-04 | 171 | 10 | 2 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-04 | 171 | 10 | 2 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | CD8+_Memory_T_cell-FLU-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.41e-04 | 172 | 10 | 2 | 45ac433dbb3796f69e886c04457b2971403050ee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-04 | 172 | 10 | 2 | 4f2303dee1f816093e580ea8a4a8d7e3e4f36368 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.41e-04 | 172 | 10 | 2 | 8d6a2a0d5f63b09a5a304a77e600a647f87e9de4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.41e-04 | 172 | 10 | 2 | 18bdf34e1b94dcb1daf00c533e3ce1a8d67fcc0e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.48e-04 | 173 | 10 | 2 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.48e-04 | 173 | 10 | 2 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | FLU-Healthy-3|FLU / Virus stimulation, Condition and Cluster | 6.48e-04 | 173 | 10 | 2 | 32b8e5b400885dbeba57a7cb2c18d882664dc285 | |
| ToppCell | FLU-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 6.48e-04 | 173 | 10 | 2 | 26e89ac86922f1cd0100cf4d1cce37e74dd31c88 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.48e-04 | 173 | 10 | 2 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.56e-04 | 174 | 10 | 2 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | Tuft-tuft-4|World / Class top | 6.56e-04 | 174 | 10 | 2 | d6f306ebf66061bf9e9742000bfedce12d277452 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tnaive/CM_CD8|blood / Manually curated celltypes from each tissue | 6.56e-04 | 174 | 10 | 2 | 8273de40552d1cca1a8fe3647fd5e4cb4bb70f99 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-04 | 174 | 10 | 2 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 6.56e-04 | 174 | 10 | 2 | 15e2b9f46404ff9575e149024b24cb17b50b02b5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.56e-04 | 174 | 10 | 2 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.63e-04 | 175 | 10 | 2 | c227fc5d1ccb69b82a96a6354913cafaf27d0eec | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Fst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.71e-04 | 176 | 10 | 2 | a1b9f8f199a028b3fa85de43fe96bc29f387bfd8 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 6.86e-04 | 178 | 10 | 2 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.86e-04 | 178 | 10 | 2 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-04 | 179 | 10 | 2 | dfd9d29281510d32f1a2e8336d2e58ef496cfd1d | |
| ToppCell | wk_15-18-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.94e-04 | 179 | 10 | 2 | b1f085e4c8d65d5cdbfaf2db80343638abb08979 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-04 | 179 | 10 | 2 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.01e-04 | 180 | 10 | 2 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.09e-04 | 181 | 10 | 2 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 7.09e-04 | 181 | 10 | 2 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Healthy-CD8+_T_naive|World / disease group, cell group and cell class | 7.17e-04 | 182 | 10 | 2 | b7d9f02c29c92c8803e11f967ad6eea032cb4224 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD8_Naive|Leuk-UTI / Disease, Lineage and Cell Type | 7.17e-04 | 182 | 10 | 2 | 3500a826d86beb98980e2b24e074b02e8e2f957e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.17e-04 | 182 | 10 | 2 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.17e-04 | 182 | 10 | 2 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.17e-04 | 182 | 10 | 2 | 31efc06d6b073e8e341648207093e5f33c6f9183 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-04 | 182 | 10 | 2 | e3248d108b51c49ca2c978636e13017e23b53860 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 10 | 2 | 01ad18f198195ce341bae01a1c8c253cc4607766 | |
| ToppCell | Healthy-CD8+_T_naive|Healthy / disease group, cell group and cell class | 7.25e-04 | 183 | 10 | 2 | 5e7a611cfb8a21106bb07361878ccc77ff251502 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-04 | 183 | 10 | 2 | 99ab7a43527eb226027efbcd8c0b6a8e46fc3c93 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 10 | 2 | b5d041d0a3506c33de72bf14fa0443f4410fddf1 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.25e-04 | 183 | 10 | 2 | dbc7ec66da5930c2bf4e0405937b054e04c22a34 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 10 | 2 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 10 | 2 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.25e-04 | 183 | 10 | 2 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-04 | 183 | 10 | 2 | 28916f0597690ff534578be2cb715b485cb1de1a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 10 | 2 | 7961e05c6e9964da159059c6bfb4f7e7e14308c2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-04 | 184 | 10 | 2 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-04 | 184 | 10 | 2 | e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.33e-04 | 184 | 10 | 2 | 9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 7.33e-04 | 184 | 10 | 2 | 0299cd30a3ea8e861a9d529043c204048ae21d29 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.33e-04 | 184 | 10 | 2 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 7.33e-04 | 184 | 10 | 2 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.41e-04 | 185 | 10 | 2 | 863a3d44c1f115942d7a2a2b63a92fe5fc768814 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.41e-04 | 185 | 10 | 2 | fcd95bc074e982fc7b8fd48d2e80038b9ea35ebb | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 7.41e-04 | 185 | 10 | 2 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.41e-04 | 185 | 10 | 2 | 27dbfcd40ec832d5cf757331d8af3b5176ae90fb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.41e-04 | 185 | 10 | 2 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-04 | 185 | 10 | 2 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.41e-04 | 185 | 10 | 2 | 1c23891e4d75f99296d1304af7a9d6c3cb28d04c | |
| Computational | Intermediate filaments. | 7.08e-04 | 75 | 6 | 2 | MODULE_154 | |
| Computational | Genes in the cancer module 297. | 8.05e-04 | 80 | 6 | 2 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 8.05e-04 | 80 | 6 | 2 | MODULE_357 | |
| Drug | Gut factor | 1.82e-05 | 15 | 10 | 2 | CID000123786 | |
| Drug | Josamycin [16846-24-5]; Up 200; 4.8uM; HL60; HG-U133A | 6.99e-05 | 194 | 10 | 3 | 2034_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 7.21e-05 | 196 | 10 | 3 | 2798_UP | |
| Drug | AC1L9NAZ | 7.43e-05 | 198 | 10 | 3 | CID000449606 | |
| Drug | NSC49080 | 9.10e-05 | 33 | 10 | 2 | CID000002192 | |
| Drug | lead stearate | 5.94e-04 | 84 | 10 | 2 | CID000061258 | |
| Drug | 3-amino-9-ethylcarbazole | 7.12e-04 | 92 | 10 | 2 | CID000008588 | |
| Drug | erythromycin stearate | 1.03e-03 | 111 | 10 | 2 | CID000012559 | |
| Drug | GDP-Man | 1.64e-03 | 140 | 10 | 2 | CID000000732 | |
| Drug | Diethylstilbestrol | 1.71e-03 | 1305 | 10 | 4 | ctd:D004054 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 155 | 10 | 2 | 6817_DN | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 2.15e-03 | 161 | 10 | 2 | 3556_DN | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.60e-03 | 177 | 10 | 2 | 4652_DN | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; PC3; HT_HG-U133A | 2.62e-03 | 178 | 10 | 2 | 5779_UP | |
| Drug | Mebendazole [31431-39-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.68e-03 | 180 | 10 | 2 | 4694_UP | |
| Drug | STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A | 2.74e-03 | 182 | 10 | 2 | 6427_UP | |
| Drug | fullerene C60 | 2.84e-03 | 1498 | 10 | 4 | ctd:C069837 | |
| Drug | Picrotoxinin [17617-45-7]; Down 200; 13.6uM; HL60; HT_HG-U133A | 2.92e-03 | 188 | 10 | 2 | 2161_DN | |
| Drug | AG-012559 [369370-06-9]; Down 200; 10uM; PC3; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 6920_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 4450_UP | |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 6717_DN | |
| Drug | Loxapine succinate [27833-64-3]; Up 200; 9uM; PC3; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 6694_UP | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; HL60; HT_HG-U133A | 2.98e-03 | 190 | 10 | 2 | 3144_DN | |
| Drug | Digoxigenin [1672-46-4]; Down 200; 10.2uM; HL60; HT_HG-U133A | 2.98e-03 | 190 | 10 | 2 | 3060_DN | |
| Drug | Prostaglandin E1; Up 200; 10uM; PC3; HT_HG-U133A | 2.98e-03 | 190 | 10 | 2 | 6571_UP | |
| Drug | retinoic acid; Up 200; 1uM; PC3; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 1211_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 4299_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 7503_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; HL60; HT_HG-U133A | 3.01e-03 | 191 | 10 | 2 | 1302_DN | |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 2947_DN | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 6573_UP | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; PC3; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 6714_DN | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 4816_DN | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.04e-03 | 192 | 10 | 2 | 6752_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.08e-03 | 193 | 10 | 2 | 6716_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 3747_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 6918_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 3938_DN | |
| Drug | Altretamine [654-05-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 6467_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 6995_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; HL60; HT_HG-U133A | 3.11e-03 | 194 | 10 | 2 | 1293_UP | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; HL60; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 3001_DN | |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 6921_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 4653_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 7509_DN | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 7099_DN | |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; HL60; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 2426_UP | |
| Drug | Arecoline hydrobromide [300-08-3]; Down 200; 17uM; HL60; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 1303_DN | |
| Drug | radicicol; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5952_UP | |
| Drug | PHA-00665752 [477575-56-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 6578_DN | |
| Drug | Gliclazide [21187-98-4]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.14e-03 | 195 | 10 | 2 | 5089_DN | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 6568_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5881_DN | |
| Drug | PHA-00767505E [723337-45-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 6596_DN | |
| Drug | Letrozole [112809-51-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4824_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3965_DN | |
| Drug | Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 3517_UP | |
| Drug | Gly-His-Lys acetate salt; Up 200; 1uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 6570_UP | |
| Drug | Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; HL60; HG-U133A | 3.17e-03 | 196 | 10 | 2 | 1418_UP | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; HL60; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 2441_UP | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5704_UP | |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 5063_UP | |
| Drug | Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 6905_DN | |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4805_UP | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 2280_UP | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 3.17e-03 | 196 | 10 | 2 | 4567_UP | |
| Disease | hoarding disorder | 6.47e-05 | 36 | 10 | 2 | EFO_0803361 | |
| Disease | electroencephalogram measurement | 2.76e-04 | 74 | 10 | 2 | EFO_0004357 | |
| Disease | Crohn's disease | 3.68e-04 | 441 | 10 | 3 | EFO_0000384 | |
| Disease | pelvic organ prolapse | 9.26e-04 | 136 | 10 | 2 | EFO_0004710 | |
| Disease | Colorectal Carcinoma | 1.42e-03 | 702 | 10 | 3 | C0009402 | |
| Disease | trauma exposure measurement | 1.47e-03 | 172 | 10 | 2 | EFO_0010703 | |
| Disease | diffuse plaque measurement | 1.77e-03 | 758 | 10 | 3 | EFO_0010699 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 2.07e-03 | 801 | 10 | 3 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | obesity | 2.86e-03 | 241 | 10 | 2 | EFO_0001073 | |
| Disease | Colorectal Neoplasms | 3.76e-03 | 277 | 10 | 2 | C0009404 | |
| Disease | neuroimaging measurement | 4.70e-03 | 1069 | 10 | 3 | EFO_0004346 | |
| Disease | Malignant neoplasm of breast | 4.76e-03 | 1074 | 10 | 3 | C0006142 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECHPSGCLIDLCMQM | 636 | Q32M45 | |
| MCECPPGFSGMDCEE | 896 | Q04721 | |
| MCRRMVCDCENPTVD | 671 | Q99435 | |
| DEMGDDCNCPCDMDC | 206 | Q9P1T7 | |
| DCNCPCDMDCGIMDA | 211 | Q9P1T7 | |
| HMACMVENECEDPSQ | 1266 | P52701 | |
| MCMDVDECERHPCGN | 1931 | P35556 | |
| PIQVECMSCSMDCDV | 1296 | Q15262 | |
| CAQCEMEHSADGLME | 181 | Q5T4F7 | |
| TCPMGQVNADCDACM | 206 | O75339 | |
| CDACMCQDFMLHGAV | 216 | O75339 | |
| VAVCDMMEGKCPCPE | 251 | Q9H832 |